Evidence map›Paper›PMID 40841896›Full record

ArticleBMC pregnancy and childbirth2025

Associations of CRP and PCT levels with obstetric and neonatal outcomes: a prospective study.

Merve Ates, Pinar Calis, A Gokcen Artiktay, Canan Yilmaz, Ibrahim Murat Hirfanoglu, Ahmet Erdem, Mehmet Erdem

Abstract read
In one paragraph

Article in BMC pregnancy and childbirth, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Merve AtesDepartment of Obstetrics and Gynecology, Gazi University Faculty of Medicine, Besevler, Ankara, 06650, Turkey. merve.kynrc@gmail.com.
Pinar CalisDepartment of Obstetrics and Gynecology, Gazi University Faculty of Medicine, Besevler, Ankara, 06650, Turkey.
A Gokcen ArtiktayDepartment of Obstetrics and Gynecology, Gazi University Faculty of Medicine, Besevler, Ankara, 06650, Turkey.
Canan YilmazDepartment of Medical Biochemistry, Gazi University Faculty of Medicine, Ankara, 06560, Turkey.
Ibrahim Murat HirfanogluDepartment of Neonatology, Gazi University Faculty of Medicine, Ankara, 06500, Turkey.
Ahmet ErdemDepartment of Obstetrics and Gynecology, Gazi University Faculty of Medicine, Besevler, Ankara, 06650, Turkey.
Mehmet ErdemDepartment of Obstetrics and Gynecology, Gazi University Faculty of Medicine, Besevler, Ankara, 06650, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundC-reactive protein (CRP) and procalcitonin (PCT) levels may be elevated under inflammatory conditions. The aim of this study was to determine the cutoff values for CRP and PCT levels during pregnancy and to evaluate the associations of any elevation with obstetric and neonatal outcomes.

methodsThis prospective study was conducted from June 2023 to December 2024. The study included 411 singleton pregnant women aged 18-44 years with no apparent clinical infection. Venous blood samples were collected during the visit for routine antenatal care during all three trimesters. Categorical variables were compared between groups via the chi-square test, and Student's t-test was used to compare normally distributed continuous variables. The area under the ROC curve was used to detect sensitivity and specificity and to set a cutoff. Regression analysis was performed to evaluate the effects of age and BMI on obstetric complications. P values < 0.05 were considered statistically significant.

resultsThe mean CRP and PCT levels in the study group were 10.9 ± 16.7 and 0.17 ± 1.8, respectively. ROC curves were used to analyze the ability of CRP and PCT values during pregnancy to predict obstetric complications. A cutoff value of 6.72 mg/L (sensitivity: 67%; specificity: 60%) and 0.0385 (sensitivity: 60%; specificity: 61%) was revealed. The incidence of composite obstetric complications was significantly greater in patients with elevated CRP levels (32.4% vs. 67.6%) (p < 0.001). The incidence of preeclampsia, GHT, neonatal complications and the need for intensive care were significantly greater in patients with CRP levels > 6.72. The incidence of composite obstetric complications was significantly greater in patients with elevated PCT levels (59% vs. 41%) (p < 0.001). Patients with elevated PCT levels had a greater frequency of preterm labor or PPROM, neonatal complications, need for intensive care, and RDS.

conclusionsElevated CRP and PCT are associated with increased rates of obstetric and neonatal complications. CRP and PCT, which are inexpensive and available, may be used for screening to predict obstetric and neonatal complications during patient follow-up.

trial registrationThis study was approved by the institutional ethical committee of the Gazi University Faculty of Medicine (Approval No:05.06.2023/479).

Indexed as

C-Reactive ProteinPregnancy ComplicationsProcalcitoninAdolescentAdultBiomarkersFemaleHumansInfant, NewbornPregnancyPregnancy OutcomeProspective StudiesROC CurveYoung AdultBiomarkersC-Reactive ProteinProcalcitoninC-reactive proteinNeonatal outcomesObstetric complicationsPregnancyProcalcitonin

Identifiers

PMID40841896
PMCPMC12369188

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.